About Us

Our vision is a world where people return to health as soon as possible.

Our purpose is to create rapid, accurate diagnostic tools that use digital technology to link people to optimal therapy.

WHAT WE DO

Our team is focused on developing, manufacturing and commercializing the next generation of digital diagnostic products for clinicians and consumers. Our core focus is the accurate diagnosis of common, burdensome illnesses where our technology will have maximum impact on healthcare outcomes. Our products are distinguished by their digital capabilities, technical performance, ease of use and rapid time to result.

Our Story hidden page marker

OUR STORY

 Note from Dr Sean Parsons – Chief Executive Officer & Founder

The swine flu pandemic of 2009 provided the impetus to found Ellume. I was working as a doctor in a busy emergency department where scores of people were presenting wanting to know if they had flu and, if so, what could be done to manage it. Laboratory tests were taking days to return results and the available rapid tests lacked accuracy, so clinicians were forced to make treatment decisions without a reliable biological diagnosis. Unwarranted prescribing of both antivirals and antibiotics was essentially unavoidable, as was inappropriate non-prescribing for influenza infected patients. There was clearly an unmet and critical need for a faster, simpler, reliable way to diagnose and manage influenza.

The technology Ellume developed to meet this unmet need evolved over several years and consists of several layers of innovation (described in ‘Our Technology’). Investment in the core science has been significant and has resulted in multiple patent families with supporting national-phase applications. Around this core science we’ve wrapped simple, intuitive user interfaces with smart-device connectivity to create unique products.

The technology has enabled us to create the influenza product as we envisaged, but it has also generated products for other conditions, including Respiratory syncytial virus, Group A Streptococcus and Tuberculosis. We have created genuine platform technology and we look forward to releasing multiple products both with our valued commercialization partners and independently under the ellume·lab brand in coming years.

As smart-phone technology has evolved, we’ve tailored our products for use as a hub for personal healthcare. Ellume technology is well suited to this use and the rapid expansion of telemedicine for common conditions provides a natural link for patients seeking clinical management. There will be further release of information in coming months and we’re excited about future Ellume products. Stay tuned.

Board members hidden page marker

Corporate Social Responsibility hidden page marker

Corporate Social Responsibility

We believe in creating products which will have a substantial positive impact on global illnesses, such as influenza, tuberculosis and resistant micro-organisms. By doing this, we believe we can enable people around the world to live happier, healthier lives.